Gaucher is a genetic disease where glucocerebroside ... with Afinitor recommended for those with NETs of gastrointestinal or lung origin where their disease has progressed. Vertex's gene-editing ...

FDA aligned on single-arm Phase 3 study to support potential accelerated and full approvalOn track to dose first patient in Phase 3 trial in ...